Davis George Eric (CIK 0001380710)

Latest company ownership

BMRN - BIOMARIN PHARMACEUTICAL INC
Role: EVP, Chief Legal Officer
Shares held
30,020
Last filed at
Mar 18, 2025
Confidence Score
49.6
2025Q4
Confidence Score History
2016Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 14, 2025 Mar 18, 2025 BIOMARIN PHARMACEUTICAL INC EVP, Chief Legal Officer Sell 17.5 -3,309 -3.84% ✗ $1.1M
May 28, 2024 May 30, 2024 BIOMARIN PHARMACEUTICAL INC EVP, Chief Legal Officer Sell 5.0 -40,850 -42.11% ✓ $3M
Apr 30, 2024 May 6, 2024 BIOMARIN PHARMACEUTICAL INC EVP, Chief Legal Officer Sell 45.0 -1,549 -1.36% ✓ $157.3K
Mar 28, 2024 Apr 1, 2024 BIOMARIN PHARMACEUTICAL INC EVP, Chief Legal Officer Sell 5.0 -24,602 -30.58% ✓ $2.2M
Mar 15, 2024 Mar 19, 2024 BIOMARIN PHARMACEUTICAL INC EVP, Chief Legal Officer Sell 17.5 -11,439 -12.45% ✗ $1.8M
Dec 13, 2023 Dec 14, 2023 BIOMARIN PHARMACEUTICAL INC EVP, Chief Legal Officer Sell 15.0 -13,764 -19.81% ✓ $1.3M
Aug 8, 2023 Aug 9, 2023 BIOMARIN PHARMACEUTICAL INC EVP, Chief Legal Officer Sell 20.0 -11,000 -13.67% ✗ $983.7K
Mar 15, 2023 Mar 17, 2023 BIOMARIN PHARMACEUTICAL INC EVP, Chief Legal Officer Sell 17.5 -14,082 -14.91% ✗ $2.1M
Aug 9, 2022 Aug 11, 2022 BIOMARIN PHARMACEUTICAL INC EVP, Chief Legal Officer Sell 17.5 -51,216 -31.67% ✗ $4.9M
Jul 8, 2022 Jul 11, 2022 BIOMARIN PHARMACEUTICAL INC EVP, Chief Legal Officer Sell 22.5 -7,398 -11.15% ✓ $665.8K
Apr 29, 2022 May 4, 2022 BIOMARIN PHARMACEUTICAL INC EVP, Chief Legal Officer Sell 20.0 -15,006 -10.16% ✓ $1.2M
Mar 21, 2022 Mar 23, 2022 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 26.3 -6,129 -8.82% ✓ $498.2K
Mar 15, 2022 Mar 17, 2022 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 85.0 +1,498 2.20% ✗ $749.9K
Aug 2, 2021 Aug 4, 2021 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 26.3 -5,518 -8.61% ✓ $423.2K
Apr 30, 2021 May 4, 2021 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 30.0 -4,332 -6.33% ✓ $365.9K
Apr 19, 2021 Apr 20, 2021 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 37.5 -2,709 -3.81% ✓ $215.6K
Mar 22, 2021 Mar 23, 2021 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 22.5 -1,391 -1.99% ✗ $109.2K
Mar 15, 2021 Mar 17, 2021 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 92.5 +4,154 6.32% ✗ $489.7K
Apr 30, 2020 May 4, 2020 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 15.0 -12,165 -15.63% ✓ $1.1M
Mar 20, 2020 Mar 24, 2020 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 22.5 -3,309 -4.08% ✗ $241.7K
Mar 13, 2020 Mar 17, 2020 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 90.0 +2,856 3.65% ✗ $612.1K
Nov 26, 2019 Nov 27, 2019 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 35.0 -3,190 -4.44% ✓ $254.1K
Mar 22, 2019 Mar 26, 2019 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 26.3 -6,672 -8.49% ✓ $586.8K
Mar 19, 2019 Mar 21, 2019 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 26.3 -7,907 -9.14% ✓ $742.6K
Mar 15, 2019 Mar 19, 2019 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 90.0 +2,722 3.25% ✗ $628.4K
Mar 1, 2019 Mar 5, 2019 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 95.0 +11,013 15.14% ✗ $79.6K
Sep 14, 2018 Sep 18, 2018 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 22.5 -2,216 -2.96% ✗ $220.4K
Sep 13, 2018 Sep 17, 2018 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 17.5 -12,000 -13.80% ✗ $1.2M
Apr 30, 2018 Jun 6, 2018 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 22.5 -1,105 -1.25% ✗ $130.2K
Mar 22, 2018 Apr 27, 2018 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 20.0 -3,308 -3.50% ✗ $269.1K
Mar 23, 2018 Mar 27, 2018 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 35.0 -3,350 -3.67% ✓ $272.5K
Mar 22, 2018 Mar 26, 2018 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 20.0 -3,295 -3.48% ✗ $268.1K
Mar 16, 2018 Mar 20, 2018 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 35.0 -3,818 -3.88% ✓ $320.3K
Mar 15, 2018 Mar 19, 2018 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 92.5 +8,363 9.28% ✗ $314K
Mar 5, 2018 Mar 7, 2018 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 41.3 -2,105 -2.28% ✓ $166.4K
Mar 2, 2018 Mar 6, 2018 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 22.5 -2,071 -2.20% ✗ $165.4K
Feb 1, 2018 Feb 5, 2018 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 5.0 -30,000 -26.56% ✓ $2.7M
Nov 30, 2017 Dec 4, 2017 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 22.5 -1,200 -1.43% ✗ $102.8K
Jun 23, 2017 Jun 27, 2017 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 22.5 -9,844 -10.54% ✓ $950.9K
Jun 5, 2017 Jun 7, 2017 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 20.0 -9,471 -11.30% ✗ $862.2K
Jun 2, 2017 Jun 6, 2017 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 22.5 -1,488 -1.74% ✗ $135K
May 15, 2017 May 17, 2017 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 22.5 -1,096 -1.29% ✗ $100.3K
Apr 28, 2017 May 9, 2017 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 20.0 -2,198 -1.27% ✗ $250.9K
Mar 15, 2017 Mar 17, 2017 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 30.0 -5,233 -6.63% ✓ $482.8K
Mar 6, 2017 Mar 8, 2017 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 45.0 -1,498 -1.86% ✓ $139.8K
Mar 3, 2017 Mar 7, 2017 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 22.5 -1,596 -1.95% ✗ $149.9K
Oct 7, 2016 Nov 22, 2016 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 35.0 -5,360 -3.65% ✓ $452.1K
Aug 1, 2016 Aug 3, 2016 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 41.3 -2,167 -2.96% ✓ $216.7K
Jun 16, 2016 Jul 11, 2016 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 37.5 -2,287 -3.13% ✓ $195K
Jun 3, 2016 Jun 7, 2016 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 22.5 -1,488 -2.00% ✗ $133.9K
May 13, 2016 May 17, 2016 BIOMARIN PHARMACEUTICAL INC EVP, General Counsel Sell 22.5 -1,096 -1.45% ✗ $90.7K